Kidney Disease News and Research

RSS

Overweight, obesity in adolescence and early adulthood linked to increased stroke risk in women

In an analysis of more than 50 years of health data, women who had overweight or obesity at age 14 or 31 were more likely to have an ischemic (clot-caused) stroke before age 55, according to research published today in Stroke, the peer-reviewed scientific journal of the American Stroke Association, a division of the American Heart Association.

6 Jun 2024

Researchers discover age-related changes in the lipid metabolism of mice

Researchers at the RIKEN Center for Integrative Medical Sciences (IMS) have discovered numerous age-related changes in the lipid metabolism of mice, across both organs and sexes.

4 Jun 2024

Older individuals with multimorbidity at increased risk of hospitalization during hot weather

Australians are no strangers to long, hot summers, but new Griffith University research has looked at the impact of hot weather on patients with pre-existing chronic diseases and how it increases their risk of being hospitalized.

4 Jun 2024

Study: Fewer than one-quarter of heart attack patients receive dietary counseling in the aftermath

Although diet is the leading contributor to premature death from heart disease in the United States, fewer than one-quarter of people who undergo major heart events receive dietary counseling in the aftermath, a study finds.

4 Jun 2024

Long-term health risks linger for severe COVID-19 patients three years after hospitalization

Three years after severe COVID-19 hospitalization, significant risks of mortality and long-term symptoms persist, impacting overall health and quality of life.

2 Jun 2024

The nutritional value of ready-to-use meat alternatives in Belgium

Researchers compare the nutrient content of ready-to-use meat alternatives with real meat products.

31 May 2024

Pregnant women less likely to suffer long COVID, study finds

A new study in EClinicalMedicine found that SARS-CoV-2 infection during pregnancy is linked to a lower risk of developing post-acute sequelae (PASC) compared to infection outside of pregnancy.

29 May 2024

Study finds kidney complications following heart failure hospitalization

In a study of Medicare beneficiaries, researchers from Brigham and Women's Hospital found that one year after hospitalization for heart failure, 6 percent of patients had progressed to dialysis.

29 May 2024

Semaglutide shows significant kidney benefits in non-diabetic obese patients with heart disease

A recent study in Nature Medicine shows semaglutide reduces kidney risks in non-diabetic obese patients with cardiovascular disease by 22%. The SELECT trial results highlight semaglutide's benefits for kidney function and overall cardiovascular health.

28 May 2024

Oral semaglutide shows promising results for type 2 diabetes in routine clinical settings

Semaglutide and its effects on glycemic control, body weight (BW), and tolerability in routine clinical practice.

28 May 2024

Taking semaglutide once weekly may lower the chances of kidney disease, says study

The effects of semaglutide (administered once weekly) on the outcomes of kidney disease.

28 May 2024

Study finds rise in hospitalizations for ischemic priapism

Researchers analyzed nationwide data from Germany to evaluate trends and outcomes in hospitalized cases of high- and low-flow priapism, finding increased hospitalizations for ischemic priapism and reduced cases linked to sickle cell disease.

26 May 2024

SELECT trial shows semaglutide reduces kidney decline in obese patients

The SELECT Trial has revealed the potential of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in combating kidney function decline among individuals with overweight or obesity and established cardiovascular disease but without diabetes.

25 May 2024

Flavonoid-rich diet slashes type 2 diabetes risk by up to 28%, new study reveals

Increasing the intake of flavonoid-rich foods significantly reduces the risk of developing type 2 diabetes, according to a study in Nutrition & Diabetes.

23 May 2024

Researchers discover advances in predicting kidney failure in type 1 diabetes patients

In a paper published today in Science Translational Medicine, researchers from City of Hope, one of the largest cancer research and treatment organizations in the United States and a leading research center for diabetes and other life-threatening illnesses, report that they have discovered advances in predicting kidney failure in type 1 diabetes (T1D) patients.

22 May 2024

Study reveals endurance exercise's impact on the biological molecules of animals and humans

As part of an ongoing national research effort to better understand how physical activity improves health and prevents disease, seven University of Colorado Department of Medicine faculty members contributed to an article recently published in Nature, an international journal of science.

22 May 2024

New model predicts kidney function recovery after acute kidney injury

Researchers at the University of Cincinnati College of Medicine have created a scoring model that uses key health indicators to accurately predict recovery for patients who experience kidney failure due to acute kidney injury (AKI), which occurs when kidneys stop working properly and can range from minor loss of kidney function to complete failure.

21 May 2024

Men face higher risk of diabetes complications than women, study finds

Men are at greater risk than women of the major health effects of diabetes (types 1 and 2), suggests a long term study published online in the Journal of Epidemiology & Community Health.

16 May 2024

Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic

Closed Loop Medicine Ltd, a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, and Pharmanovia, a global pharmaceutical company that commercializes novel medicines and revitalizes, extends and expands the lifecycle of established medicines, today announced the initiation of their OptiZest study, ID: NCT06372470, and first patient recruitment.

From Closed Loop Medicine 16 May 2024

Anti-obesity medications slash heart disease risk in obese patients, study finds

A study in the journal Obesity evaluated the impact of new anti-obesity medications (AOMs) on cardiovascular disease (CVD) among obese individuals, finding that these medications reduce the risk of CVD complications, particularly heart failure and atrial fibrillation.

15 May 2024

Kidney Disease News and Research

Overweight, obesity in adolescence and early adulthood linked to increased stroke risk in women

Researchers discover age-related changes in the lipid metabolism of mice

Older individuals with multimorbidity at increased risk of hospitalization during hot weather

Study: Fewer than one-quarter of heart attack patients receive dietary counseling in the aftermath

Long-term health risks linger for severe COVID-19 patients three years after hospitalization

The nutritional value of ready-to-use meat alternatives in Belgium

Pregnant women less likely to suffer long COVID, study finds

Study finds kidney complications following heart failure hospitalization

Semaglutide shows significant kidney benefits in non-diabetic obese patients with heart disease

Oral semaglutide shows promising results for type 2 diabetes in routine clinical settings

Taking semaglutide once weekly may lower the chances of kidney disease, says study

Study finds rise in hospitalizations for ischemic priapism

SELECT trial shows semaglutide reduces kidney decline in obese patients

Flavonoid-rich diet slashes type 2 diabetes risk by up to 28%, new study reveals

Researchers discover advances in predicting kidney failure in type 1 diabetes patients

Study reveals endurance exercise's impact on the biological molecules of animals and humans

New model predicts kidney function recovery after acute kidney injury

Men face higher risk of diabetes complications than women, study finds

Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic

Anti-obesity medications slash heart disease risk in obese patients, study finds

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News